Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$6.97M Buy
366,200
+279,100
+320% +$6.17M 0.27% 101
2019
Q1
$2.47M Sell
87,100
-315,000
-78% -$9.19M 0.1% 136
2018
Q4
$11M Sell
402,100
-140,500
-26% -$4.55M 0.5% 74
2018
Q3
$19.9M Buy
542,600
+401,300
+284% +$15.1M 0.83% 31
2018
Q2
$5.11M Sell
141,300
-343,700
-71% -$13.5M 0.22% 130
2018
Q1
$20M Buy
+485,000
New +$20.7M 1.02% 19
2017
Q4
Hold
0
19

Other funds holding VTRS

Delek Group's VTRS Position: Q2 2019 in Review

Delek Group reduced its Viatris (VTRS) stake by 0.67% in Q2 2019, selling an estimated $411K and leaving 2,775,111 shares worth $51.6M. The position accounts for 2% of the portfolio, ranked #5.

Delek Group first reported a position in VTRS in Q4 2017 and has held it in 7 quarters since. The position peaked at $105M in Q3 2018. 439 funds tracked by Wall St. Rank hold VTRS as of Q2 2019.

  • Delek Group held 2,775,111 shares of Viatris worth $51.6M as of Q2 2019.
  • Delek Group sold 18,600 Viatris shares in Q2 2019, an estimated $411K.
  • Viatris made up 2% of Delek Group's portfolio in Q2 2019, its #5 holding.
  • Delek Group first reported a position in Viatris in Q4 2017 and has held it in 7 quarters since.
  • Delek Group's Viatris position peaked at $105M in Q3 2018.
  • 439 funds tracked by Wall St. Rank held Viatris as of Q2 2019.

Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.